Atlas Trials

Hepatomegaly

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Hepatomegaly

RecordFirmDate
Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders (NCT03801434)William Shomali2019-11-15
Prevalence of Hepatomegaly in Children and Adolescents With Type 1 Diabetes Mellitus (NCT03666117)Assiut University2019-01-01
Biomarker for Sly Disease (MPS VII) (BioSly) (NCT02298699)CENTOGENE GmbH Rostock2018-08-20
Biomarker for Gaucher Disease: BioGaucher (BioGaucher) (NCT01331642)CENTOGENE GmbH Rostock2018-08-20
Biomarker for Farber Disease (BioFarber) (NCT02298634)CENTOGENE GmbH Rostock2018-08-20
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis (NCT03499808)SWOG Cancer Research Network2018-06-06
Nivolumab in Treating Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Post-Polycythemia Vera Myelofibrosis (NCT02421354)M.D. Anderson Cancer Center2015-05-14
Open-Label Extension of LOCKCYST Trial (NCT00771888)Radboud University Medical Center2008-04-01
Lanreotide as Treatment of Polycystic Livers (NCT00565097)Radboud University Medical Center2007-10-01
Octreotide in Severe Polycystic Liver Disease (NCT00426153)Mayo Clinic2007-01-01

Track Hepatomegaly automatically

Every clearance here is in the API, with alerts when new ones post.